Abstract
Tobacco BY-2 cells are an attractive platform for the manufacture of a variety of biopharmaceutical proteins, including antibodies. Here, we describe the scaled-up cultivation of human IgG–secreting BY-2 cells in a 200 L orbitally shaken disposable bioreactor, resulting in cell growth and recombinant protein yields that are proportionately comparable with those obtained from cultivations in 500 mL shake flasks. Furthermore, we present an efficient downstream process for antibody recovery from the viscous spent culture medium using expanded bed adsorption (EBA) chromatography.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Christou P (2013) From medicinal plants to medicines in plants: plant factories for the production of valuable pharmaceuticals. Curr Pharm Des 19:5469–5470
Doran PM (2013) Therapeutically important proteins from in vitro plant tissue culture systems. Curr Med Chem 20:1047–1055
Fischer R, Schillberg S, Buyel JF et al (2013) Commercial aspects of pharmaceutical protein production in plants. Curr Pharm Des 19:5471–5477
Twyman RM, Stoger E, Schillberg S et al (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21:570–578
Basaran P, Rodríguez-Cerezo E (2008) Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol 28:153–172
Hofbauer A, Stoger E (2013) Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues. Curr Pharm Des 19:5495–5502
Häkkinen ST, Raven N, Henquet M et al (2014) Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody. Biotechnol Bioeng 11:336–346
Rival S, Wisniewski J-P, Langlais A et al (2008) Spirodela (duckweed) as an alternative production system for pharmaceuticals: a case study, aprotinin. Transgenic Res 17:503–513
Woodard SL, Wilken LR, Barros GOF et al (2009) Evaluation of monoclonal antibody and phenolic extraction from transgenic Lemna for purification process development. Biotechnol Bioeng 104:562–571
Hellwig S, Drossard J, Twyman RM et al (2004) Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 22:1415–1422
Walmsley AM, Doran PM (2012) Foreign protein production using plant cells: opportunities and challenges. Biotechnol Adv 30:385–386
Nagata T, Nemoto Y (1992) Tobacco BY-2 cell line as the “HeLa” cell in the cell biology of higher plants. Int Rev Cytol 132:1–30
Schillberg S, Raven N, Fischer R et al (2013) Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. Curr Pharm Des 19:5531–5542
Fischer R, Schillberg S, Hellwig S et al (2012) GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol Adv 30:434–439
Eibl R, Kaiser S, Lombriser R et al (2010) Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology. Appl Microbiol Biotechnol 86:41–49
Eibl R, Eibl D (2006) Design and use of the wave bioreactor for plant cell culture. In: Gupta SD, Ibaraki Y (eds) Plant tissue culture engineering. Springer, Dordrecht, Netherlands, pp 203–227
Eibl R, Eibl D (2009) Design of bioreactors suitable for plant cell and tissue cultures. Phytochem Rev 7:593–598
Georgiev MI, Eibl R, Zhong J-J (2013) Hosting the plant cells in vitro: recent trends in bioreactors. Appl Microbiol Biotechnol 97:3787–3800
Zhang X, Stettler M, De Sanctis D et al (2010) Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale. Adv Biochem Eng Biotechnol 115:33–53
Fairbanks G, Steck TL, Wallach DF (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10:2606–2617
Kirchhoff J, Raven N, Boes A et al (2012) Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting. Plant Biotechnol J 10:936–944
Acknowledgement
This work was supported by the European Union Seventh Framework Program under grant agreement no. 227420 (CoMoFarm).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Raven, N., Schillberg, S., Rasche, S. (2016). Plant Cell-Based Recombinant Antibody Manufacturing with a 200 L Orbitally Shaken Disposable Bioreactor. In: MacDonald, J., Kolotilin, I., Menassa, R. (eds) Recombinant Proteins from Plants. Methods in Molecular Biology, vol 1385. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3289-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3289-4_12
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3288-7
Online ISBN: 978-1-4939-3289-4
eBook Packages: Springer Protocols